Skip to main content

Table 1 Clinical and histopathological characteristics of 132 healthy controls and 144 breast cancer patients

From: Clinical significance of serum PSA in breast cancer patients

  Healthy control
(n = 132)
Breast cancer
(n = 144)
No of cases (%) No of cases (%)
Age (mean ± SD) 53.1 ± 10.7 62.9 ± 13.2
Menopausal status Pre-menopausal 61 (46.2) 27 (18.8)
Post-menopausal 71 (53.8) 117 (81.3)
sPSA detection rate 25.8% 29.2%
sPSA ng/l (Median [IQR*]) 0 (0–3) 0 (0–4)
Clinical stage Non-MBC; Stage 0-III 67 (46.5)
MBC; Stage IV, Recurrence 77 (53.5)
Histological type Invasive ductal carcinoma 102 (70.8)
Ductal carcinoma in situ 9 (6.3)
Invasive lobular carcinoma 11 (7.6)
Lobular carcinoma in situ 0 (0)
Special type 22 (15.3)
Subtype Luminal; ER+ / HER2- 99 (68.8)
Luminal HER2; ER+ / HER2+ 16 (11.1)
HER2 enriched; ER- / HER2+ 8 (5.6)
TNBC; ER- / HER2- 21 (14.6)
Histological grade 1 82 (56.9)
2 40 (27.8)
3 22 (15.3)
Ki67 positivity < 20% 60 (41.7)
20% 81 (56.3)
Unknown 3 (2.1)
  1. *: inter-quartile range
\